ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      4,604.37
      (
      0.41%
      )
      US Tech 100
      15,699.20
      (
      0.53%
      )
      Dow Jones
      36,247.87
      (
      0.36%
      )
      Brent Oil
      75.965
      (
      0.0%
      )
      Bitcoin
      44,102.46
      (
      -0.18%
      )
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. NRX Pharmaceuticals Inc (NRXP)

      7. NRX Pharmaceuticals Inc (NRXP) News

      NRXP NRX Pharmaceuticals Inc

      0.33
      0.0001 (0.03%)
      Dec 08 2023 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      NRX Pharmaceuticals Inc NRXP NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.0001 0.03% 0.33 19:03:09
      Open Price Low Price High Price Close Price Prev Close
      0.339 0.323 0.3467 0.3315 0.3299
      more quote information »

      Recent News

      Date Time Source Heading
      12/08/20236:10IHNWFeaturedFREEDOM HOLDINGS (FHLD) SHAREHOLDER UPDATE; Freedom, Holdings Inc symbol: FHLD 15C-211 nears final approval from FINRA
      11/27/202316:01PRNUSNRx Pharmaceuticals to Present at Noble Capital Markets'..
      11/22/202316:32EDGAR2Form ARS - Annual Report to Security Holders
      11/22/202316:31EDGAR2Form DEF 14A - Other definitive proxy statements
      11/21/202317:23EDGAR2Form 8-K - Current report
      11/13/202318:39PRNUSNRx Pharmaceuticals Reports Third Quarter 2023 Financial..
      11/07/202306:48PRNUSNRx Pharmaceuticals to Report Third Quarter 2023 Financial..
      11/06/202306:48PRNUSNRx Pharmaceuticals and Nephron Pharmaceuticals Announce..
      10/31/202306:48PRNUSNRx Pharmaceuticals Announces Signing of a Development..
      10/26/202306:48PRNUSNRx Pharmaceuticals Announces Further Alignment with FDA on..
      10/23/202316:05EDGAR2Form 8-K - Current report
      10/12/202306:48PRNUSNRx Pharmaceuticals Announces Strategic Change in..
      10/05/202306:48PRNUSNRx Pharmaceuticals to Present at 8th Annual Dawson James..
      10/02/202306:48PRNUSNRx Pharmaceuticals Announces FDA Permission to Proceed on..
      9/21/202309:35GLOBEDawson James Securities Announces October Date for 8th..
      9/18/202306:46PRNUSNRx Pharmaceuticals to Present at the Sidoti Virtual Small..
      9/15/202306:46PRNUSNRX Pharmaceuticals Announces Data Sharing Agreement..
      9/14/202316:04EDGAR2Form 8-K - Current report
      9/14/202316:01PRNUSNRx Pharmaceuticals Announces Agreement with LifeSci..
      9/11/202309:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/07/202306:47PRNUSNRx Pharmaceuticals to Present at the H.C. Wainwright 25th..
      9/06/202310:55PRNUSNRx Pharmaceuticals Announces Potent Antibacterial Activity..
      9/01/202316:48EDGAR2Form 8-K - Current report
      8/31/202317:20EDGAR2Form 8-K - Current report
      8/31/202317:18EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      8/30/202306:47PRNUSNRx Pharmaceuticals Announces Submission of an..
      8/29/202306:54PRNUSNRx Pharmaceuticals Announces Definitive Purchase Agreement..
      8/14/202317:10EDGAR2Form 8-K - Current report
      8/14/202317:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      8/14/202316:34EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/14/202316:09PRNUSNRx Pharmaceuticals Reports Second Quarter 2023 Financial..
      8/07/202306:47PRNUSNRx Pharmaceuticals to Report Second Quarter 2023 Financial..
      7/28/202317:15EDGAR2Form 8-K - Current report
      6/20/202316:01PRNUSNRx Pharmaceuticals to Present at the H.C. Wainwright 4th..
      6/09/202308:45PRNUSNRx Pharmaceuticals Announces Closing of $6.28 Million..
      6/06/202312:20PRNUSNRx Pharmaceuticals Announces $6.28 Million Registered..
      6/02/202314:20PRNUSNRx Pharmaceuticals to Host Corporate and Strategic Update..
      5/26/202309:00PRNUSNRXP SHAREHOLDER ALERT: Jakubowitz Law Notifies Shareholders..
      5/24/202309:00PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
      5/16/202306:47PRNUSNRx Pharmaceuticals Reports First Quarter 2023 Financial..
      5/10/202316:05PRNUSNRx Pharmaceuticals Reschedules First Quarter 2023 Financial..
      4/27/202316:01PRNUSNRx Pharmaceuticals to Report First Quarter 2023 Financial..
      3/30/202316:01PRNUSNRx Pharmaceuticals Reports Full Year 2022 Financial Results..
      3/27/202306:47PRNUSNRx Pharmaceuticals Announces Positive Recommendation to..
      3/17/202306:47PRNUSNRx Pharmaceuticals to Report Fourth Quarter and Full Year..
      3/09/202306:47PRNUSNRx Pharmaceuticals Announces Close of $2.9 Million..
      2/22/202306:47PRNUSNRx Pharmaceuticals Builds on Its Intellectual Property..
      2/13/202306:47PRNUSNRx Pharmaceuticals Reports Minutes of Recent U.S. Food and..
      2/02/202306:47PRNUSNRx Pharmaceuticals Reports Recommendations of Data Safety..
      1/19/202306:47PRNUSNRx Pharmaceuticals Provides Progress Update on Interactions..
      1/05/202306:47PRNUSNRx Pharmaceuticals to Present Scientific Update at the 6th..

      Your Recent History

      NASDAQ
      NRXP
      NRX Pharmaceuticals
      Delayed Upgrade Clock